These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products. McEwen J Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050 [TBL] [Abstract][Full Text] [Related]
5. [Cerebral hemorrhage associated with the use of phenylpropanolamine. Clinical cases]. Tapia J Rev Med Chil; 1996 Dec; 124(12):1499-503. PubMed ID: 9334487 [TBL] [Abstract][Full Text] [Related]
6. Phenylpropanolamine and hemorrhagic stroke. Ernst ME; Hartz A N Engl J Med; 2001 Apr; 344(14):1094; author reply 1095. PubMed ID: 11291667 [No Abstract] [Full Text] [Related]
7. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Smookler S; Bermudez AJ Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595 [TBL] [Abstract][Full Text] [Related]
8. Stroke and phenylpropanolamine use. Johnson DA; Etter HS; Reeves DM Lancet; 1983 Oct; 2(8356):970. PubMed ID: 6138529 [No Abstract] [Full Text] [Related]
9. Underreporting of hemorrhagic stroke associated with phenylpropanolamine. La Grenade L; Graham DJ; Nourjah P JAMA; 2001 Dec; 286(24):3081. PubMed ID: 11754672 [No Abstract] [Full Text] [Related]
10. Phenylpropanolamine and blood pressure. Lasagna L JAMA; 1985 May; 253(17):2491-3. PubMed ID: 3981773 [No Abstract] [Full Text] [Related]
13. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion. Gilmer G; Swartz M; Teske M; Crandall AS Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408 [No Abstract] [Full Text] [Related]
14. Phenylpropanolamine and intracranial hemorrhage risk in a Mexican population. Arauz A; Velásquez L; Cantú C; Nader J; López M; Murillo L; Aburto Y Cerebrovasc Dis; 2003; 15(3):210-4. PubMed ID: 12646782 [TBL] [Abstract][Full Text] [Related]
15. Case-control study was springboard for phenylpropanolamine action. Miller JL Am J Health Syst Pharm; 2000 Dec; 57(24):2254-5. PubMed ID: 11146967 [No Abstract] [Full Text] [Related]
16. Possible adverse effects of phenylpropanolamine (diet pills) on sympathetic nervous system function--caveat emptor! Finton CK; Barton M; Chernow B Mil Med; 1982 Dec; 147(12):1072. PubMed ID: 6817204 [No Abstract] [Full Text] [Related]
17. Acute memory loss and nominal aphasia caused by phenylpropanolamine. Puar HS South Med J; 1984 Dec; 77(12):1604-5. PubMed ID: 6505775 [TBL] [Abstract][Full Text] [Related]
18. FDA issues public health advisory on phenylpropanolamine in drug products. Meadows M FDA Consum; 2001; 35(1):9. PubMed ID: 11930934 [No Abstract] [Full Text] [Related]
19. [Norpseudoephedrine (norpseudoadrenaline) as a slimming agent is dangerous]. Terland O Tidsskr Nor Laegeforen; 1983 Oct; 103(29):2002-3. PubMed ID: 6648942 [No Abstract] [Full Text] [Related]